Aditxt, Inc. Proceeds from Related Party Debt
Aditxt, Inc. (ADTX) reported Proceeds from Related Party Debt of $678.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRelatedPartyDebt · last filed 2026-03-31
- Aditxt, Inc. proceeds from related party debt for the quarter ending 2025-12-31 was $0.00.
- Aditxt, Inc. proceeds from related party debt for the quarter ending 2025-09-30 was $185.00K.
- Aditxt, Inc. proceeds from related party debt for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Aditxt, Inc. proceeds from related party debt for the quarter ending 2024-09-30 was $0.00.
- Aditxt, Inc. proceeds from related party debt for fiscal 2025 was $678.00K, a 45.18% increase from fiscal 2024.
- Aditxt, Inc. proceeds from related party debt for fiscal 2024 was $467.00K, a 56.05% decline from fiscal 2023.
- Aditxt, Inc. proceeds from related party debt for fiscal 2023 was $1.06M, a 1228.15% increase from fiscal 2022.
- Aditxt, Inc. proceeds from related party debt for fiscal 2022 was $80.00K.
| Period end | Proceeds from Related Party Debt 3 month | Proceeds from Related Party Debt 6 month | Proceeds from Related Party Debt 9 month | Proceeds from Related Party Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $185.00K derived: sum of 2 quarters · filed 2026-03-31 | $678.00K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $185.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-18 | $678.00K 10-Q · filed 2025-11-18 | ||
| 2025-06-30 | $493.00K 10-Q · filed 2025-08-14 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-03-31 | $467.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-18 | $0.00 derived: sum of 2 quarters · filed 2025-11-18 | $467.00K 10-Q · filed 2025-11-18 | $842.00K derived: sum of 4 quarters · filed 2025-11-18 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $467.00K 10-Q · filed 2025-08-14 | $842.00K derived: sum of 3 quarters · filed 2025-08-14 | $842.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $467.00K 10-Q · filed 2025-05-15 | $842.00K derived: sum of 2 quarters · filed 2025-05-15 | $842.00K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $375.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $375.00K derived: sum of 2 quarters · filed 2025-03-31 | $1.06M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-18 | $687.52K 10-Q · filed 2024-11-18 | ||
| 2023-06-30 | $687.52K 10-Q · filed 2024-08-19 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $80.00K 10-K · filed 2024-04-16 | ||
| 2022-09-30 | $80.00K 10-Q · filed 2023-11-14 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $10.00K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $10.00K 10-Q · filed 2020-11-13 | ||
| 2019-06-30 | $10.00K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |